SAKAR HEALTHCARE
Back to Balance Sheet
|
SAKAR HEALTHCARE Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|
Total Non-Current Liabilities | ₹108 Cr | ₹94 Cr | ₹46 Cr | ₹20 Cr |
What is the latest Total Non-Current Liabilities ratio of SAKAR HEALTHCARE ?
Year | Total Non-Current Liabilities |
---|---|
Mar2023 | ₹108 Cr |
Mar2022 | ₹94 Cr |
Mar2021 | ₹46 Cr |
Mar2020 | ₹20 Cr |
How is Total Non-Current Liabilities of SAKAR HEALTHCARE Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹108 Cr | 15.99 | |
Mar2022 | ₹94 Cr | 103.03 | |
Mar2021 | ₹46 Cr | 135.46 | |
Mar2020 | ₹20 Cr | - |
Compare Total Non-Current Liabilities of peers of SAKAR HEALTHCARE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SAKAR HEALTHCARE | ₹760.9 Cr | -4.9% | -3.1% | 65.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,452.0 Cr | 1.1% | -6.6% | 56.7% | Stock Analytics | |
CIPLA | ₹113,132.0 Cr | 0.2% | -4.4% | 54.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,191.0 Cr | 4.8% | 18.9% | 23.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,512.0 Cr | 4.3% | 2.6% | 29.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,954.5 Cr | 2.2% | -4.6% | 86.6% | Stock Analytics |
SAKAR HEALTHCARE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SAKAR HEALTHCARE | -4.9% |
-3.1% |
65.1% |
SENSEX | 1% |
2.8% |
23.9% |
You may also like the below Video Courses